June 10, 2026 · Form 4 insider transaction
Doyle Mittie sold 1,084 shares of Avalo Therapeutics, Inc. at $13.10 per share, a transaction worth $14.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Includes 5,738 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.